Company
Maze Therapeutics
| Industry | clinical-stage biopharmaceutical company leveraging human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and metabolic diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Maze Therapeutics | Series D | 2024-12-03 |